AptaPharma Inc. – FDA 483, May 15, 2023
AptaPharma Inc. in Pennsauken, NJ, was inspected and received a Form 483 with six observations related to significant deficiencies in quality control, labeling, investigations, and warehousing practices. Key issues included inadequate investigations into product discrepancies like mislabeled "Alcohol Free" products, lack of control over labeling materials, and insufficient procedures for change control, audit trails, and environmental monitoring. The findings indicate a need for comprehensive improvements in the firm's quality systems and adherence to established procedures.
ID · c030fb89-e748-43a8-a12b-56e31d0a48aa
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.